Dyslipidemia management in ayurveda with dhamasa churna capsules

Phase 2

Not yet recruiting

• Conditions: Disorder of lipoprotein metabolism, unspecified. Ayurveda Condition: MEDOVRUDDHIH,

• Registration Number: CTRI/2025/05/086409
• Lead Sponsor: KLE Academy of Higher Education and Research Center

Brief Summary

Dyslipidemia has become a major worldwide health problem.  Overweight and obesity are responsible for 44% of diabetes burden, 23% of ischemic heart disease burden, and 7-41% of various cancer.  Around 1.9 billion persons worldwide in 2016 were overweight, with Almost 650 million people worldwide were obese. Many of    these    complications    are    related    to    co-morbid conditions dyslipidemia. Obesity increases cardiovascular    risk    through    risk    factors    such    as increased    fasting    plasma    triglycerides, high    LDL cholesterol, low HDL cholesterol, elevated blood glucose and insulin levels and high blood pressure.

Around 60-70% of people with obesity have dyslipidemia. In Ayurveda   dyslipidemia can   be   correlated   with medodushti which   is   considered   to   be a   disease   of Medo dhatu.

Therefore, Dhamasa is mentioned in Bhavaprakasha nighantu as Kaphamedajit so, it is considered for ongoing review.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-05-05
• Study Start: 2025-06-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Individuals of Either sex between age group 20 to 60 years of age, BMI More than 25, If any of the following levels of lipid profile criteria fulfills LDL.
• 159mg/dl, Triglycerides.
• 199mg/dl, Total Cholesterol.

Exclusion Criteria

• Individuals of age group below 20 and above 60 and having BMI below 25, LDL.
• greater than 159mg/dl, Triglycerides greater than 199mg/dl, Total cholesterol greater than 239mg/dl and suffering from systemic disorders like Hypertension, diabetes mellitus, Kidney disease, Genetic disorders, Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dhamasa Choorna is expected to be effective in Reducing Increased lipid profile level	assessed on 0th day and on 42ndday i.e, on 1st week and on 6th week

Secondary Outcome Measures

Name	Time	Method
Decrease in BMI	0th, 21st, 42nd days

Trial Locations

Locations (1)

KLE Ayurveda Hospital, shahapur; 🇮🇳 Belgaum, KARNATAKA, India

KLE Ayurveda Hospital, shahapur

🇮🇳Belgaum, KARNATAKA, India

Dr Santhosh N

Principal investigator

8618594508

santhoshgowdabelli79@gmail.com